Top Markets
Coin of the day
Shanghai Kaibao Pharmaceutical CO.,Ltd Shanghai Kaibao Pharmaceutical CO.,Ltd

Shanghai Kaibao Pharmaceutical CO.,Ltd

300039
Rank in Stocks #10244
Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research,... Shanghai Kaibao Pharmaceutical CO.,Ltd specializes in the research, development, manufacturing, and sale of modern Traditional Chinese Medicines, primarily operating within China. Its diverse product lineup features several key pharmaceutical solutions. These include: Tanreqing injection, which is extensively utilized for addressing conditions like pneumonia, acute and chronic bronchitis, and upper respiratory tract infections. Tanreqing capsules, formulated to reduce internal heat, detoxify the system, and clear phlegm. Tiopronin for injection, designed to enhance liver function for various acute and chronic hepatitis patients. Tiopronin enteric-coated tablets, prescribed as a supplementary therapy for managing chronic hepatitis. Xiongdan dropping pills, known for their efficacy in alleviating heat, calming the liver, and promoting improved vision. Established in 2000, the company's operations are based in Shanghai, China.
Share Price
$0.82890742
Last synced: 2026-08-28
Market Cap
$867.04M
Change (1 day)
-4.19%
Change (1 year)
-5.58%
Country
CN
Trade Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)

Category

Earnings for Shanghai Kaibao Pharmaceutical CO.,Ltd (300039)
Earnings in 2026 TTM: 0
According to Shanghai Kaibao Pharmaceutical CO.,Ltd latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Shanghai Kaibao Pharmaceutical CO.,Ltd from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors